Igyxos’ IGX12 brings a fresh approach to infertility treatment, aiming to improve outcomes for both men and women.

A landmark 30-year study of over four million women in England has revealed that women with endometriosis-associated infertility are significantly more likely to become pregnant compared to those with ...

Women who experience infertility are more likely to develop heart and blood vessel conditions later in life, with younger women and those who undergo fertility treatments at a greater risk. The ...

Infertility affects one in six people worldwide. Now, the WHO has released its first global infertility guideline – here’s ...

Utilizing a cross-national approach, University of Arizona researcher Leslie Farland, ScD is conducting a study on infertility rates and long-term health outcomes in Mexican women through a ...

The research is being presented at the Joint Congress of ESPE and ESE in Copenhagen Denmark, 10-13 May 2025. Women who experience infertility are more likely to develop heart and blood vessel ...

JACKSONVILLE, Fla. – Infertility affects millions of people, yet it remains a difficult topic for many to discuss. Advocates and medical professionals are working to break that silence, pointing out ...

Dr Gupta explains women's reproductive age no longer runs parallel to their chronological age, due to today's lifestyle. She ...

Infertility affects millions of women worldwide, but Black women face unique challenges in reproductive health. Studies show they experience higher infertility rates compared to other racial groups, ...

Igyxos Biotherapeutics is dedicated to developing innovative treatments for infertility in both men and women. Its lead asset, IGX12, is a first-in-class potentiating monoclonal antibody designed to ...

I hope they see that, as devastating as it feels, there is a way through. And the way through is to pick up your cross and ...